Medipex established Spin-out company Zilico Ltd’s ZedScan lands CE Mark

Zilico logoZilico Ltd has received CE certification from its Notified Body for ZedScan I, a cervical cancer diagnostic device. Click here to read the press release.ZedScan Press Release

The Medipex established UK Spin-out company Zilico Ltd.’s (click here for more detail on Medipex's involvement) ground-breaking system offers quicker and more accurate detection of cervical neoplasia in real-time, enabling clinicians to improve patient management.

The ZedScan I system is used alongside colposcopy on women identified with an abnormal smear result. ZedScan offers clinical benefits by identifying the optimum biopsy site and so reducing the number of cervical biopsies required whilst also facilitating a wider use of 'select & treat'. As well as its clinical benefits, a recent independent health economic report has demonstrated that ZedScan delivers cost-effective benefits to healthcare systems.



Sign up to our e-newsletter for all the latest news and updates from Medipex.

*All fields are required